to pathogen-and danger-associated molecular patterns. Active caspase-1 promotes the processing and subsequent release of active interleukin-1β (IL-1β) and IL-18. Several types of NLRs are involved in inflammasome activation. [1] [2] [3] [4] [5] [6] Mycoplasmas are characterized by a wall-less envelope. 7 They do not possess bacterial modulins such as lipopolysaccharide (LPS), lipoteichoic acid, or murein components, but do possess membranebound lipoproteins, which are recognized by Toll-like receptor 2 (TLR2) and elicit immune responses. [8] [9] [10] [11] [12] [13] [14] [15] Mycoplasmas are generally commensal in humans, but some species are pathogens capable of causing a wide variety of diseases. 7 Mycoplasma salivarium is a member of the human oral microbial flora that preferentially inhabits the gingival sulcus 16 and is suspected of playing an etiological role in periodontal diseases, [16] [17] [18] although its etiological roles remain unknown. Interleukin-1β plays a pivotal role in the pathogenesis of periodontal diseases, by inducing the production of inflammatory mediators, osteoclast formation, matrix metalloproteinase expression, and the death of matrix-producing cells. 19 In contrast, Mycoplasma pneumoniae is a key pathogen of atypical pneumonia in humans. 20 Respiratory infection with M. pneumoniae triggers secretion of several proinflammatory cytokines, including IL-1β. 21 In addition, it has been recently reported that the NLR family, pyrin domain containing-3 (NLRP3) inflammasome activation, leading to IL-1β secretion, plays an important role in recruiting and activating the innate immune cells in the lung that are critical for M. pneumoniae clearance. 22 Hence, IL-1β production through inflammasome activation is a key regulator of the host response to pathogens and to disease outcomes.
Recently, several studies have reported that mycoplasmas activate inflammasomes to induce IL-1β production. [22] [23] [24] [25] [26] [27] We have also shown that M. salivarium and M. pneumoniae cells activate the NLRP3 inflammasome to produce IL-1β in murine dendritic cells and macrophages. 28 However, the detailed mechanism of inflammasome activation triggered by mycoplasmas is not yet fully clarified. In this study, therefore, attempts were made to determine what kinds of mycoplasmal components activate the NLRP3 inflammasome to induce IL-1β production and how they (or it) activate(s) the inflammasome.
| MATERIAL S AND ME THODS

| Chemicals
The diacylated lipopeptide FSL-1 derived from M. salivarium was synthesized as described previously. 29 Fluorescein isothiocyanateconjugated FSL-1 (FITC-FSL-1) was purchased from EMC Microcollections GmbH (Tübingen, Germany). Ultrapure Escherichia coli LPS was purchased from InvivoGen (San Diego, CA). 
| Mycoplasmas and culture conditions
| Mice
Sex-matched 8-week-old C57BL/6 (B6) mice were purchased from CLEA Japan (Tokyo, Japan). TLR2-deficient mice (TLR2
) of the same genetic background were kindly provided by Dr. Shizuo Akira, Osaka University. All mice were maintained in specific pathogenfree conditions at the animal facility of the Hokkaido University.
Caspase-1-, NLRP3-, or ASC-deficient mice (caspase-1
, respectively) of the same genetic background were maintained in specific pathogen-free conditions at the animal facility of the Tokyo Medical and Dental University.
All experiments were performed in accordance with the regulations of the Animal Care and Use Committees of both universities.
| Cell culture
Femurs and tibias prepared from caspase-1
mice at the Tokyo Medical and Dental University were sent to Hokkaido University. Femurs and tibias from B6 or TLR2 −/− mice were prepared at Hokkaido University.
Bone marrow cells were obtained from femurs and tibias as follows. The ends of the bones were cut off, and marrow tissue was eluted by irrigation with RPMI-1640 medium (Life Technologies, Grand Island, NY) containing 10% fetal bovine serum (FBS), 100 U mL −1 penicillin G, and 100 μg mL −1 streptomycin. Cells were suspended by pipetting and washed by centrifugation. The cells were cultured in a non-tissue-culture plastic 10-cm Petri dish in RPMI-1640 medium containing 10% FBS, 100 U mL −1 penicillin G, 100 μg mL −1 streptomycin, and cell-conditioned medium (ie culture supernatants derived from L929 fibroblast cells). After 7-9 days of culture, macrophages loosely adhered to the dishes were harvested by using cold PBS and then used as bone-marrow-derived macrophages (BMMs). 31 
| Cytokines
Bone-marrow-derived macrophages from B6, TLR2 
| Immunoblotting
The cell culture supernatants were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to distinguish mature IL-1β from pro-IL-1β, and proteins were transferred to a polyvinylidene fluoride membrane (Bio-Rad). These proteins were reacted with the appropriate polyclonal antibody against IL-1β (R&D Systems). 
| Digestion of lipoproteins by proteinase K
| Transfection of FSL-1 into the cytosol
B6BMMs were added to a poly-l-lysine ( 
| Localization of FSL-1 in the cytosol
B6BMMs were added to a poly-l-lysine (Sigma-Aldrich) -coated 8- as the mean ± SD of triplicate assays of a representative experiment. All of the experiments were repeated at least twice, and similar results were obtained. Mature IL-1β (mIL-1β) was evaluated by molecular weight (mIL-1β: 17.5 kDa, pro-IL-1β: 31 kDa) of the band detected by Western blotting. Student's t-test; *.01 < P < .05, **.01 < P < .001 polyclonal antibody (1/200) (AL177; AdipoGen) in 1% BSA in PBS.
The cells were then stained with Alexa 647-conjugated anti-mouse IgG antibody and/or Alexa 594-conjugated anti-rabbit IgG antibody (A21236 and/or A11012; Thermo Fisher Scientific) for 1 hour at room temperature. Confocal images were taken on a confocal laser scanning microscopy system (Nikon A1 and Ti-E, Tokyo, Japan) equipped with a Plan Apo VC 60× objective lens (NA 1.40, Nikon).
| Statistical analysis
The statistical analyses were performed using the Student's t-test.
Differences were considered significant at a P value of <.05.
| RE SULTS
| IL-1β production by BMMs in response to mycoplasmal lipoprotein/lipopeptide
We have previously shown that M. salivarium and M. pneumoniae cells induce IL-1β production by BMMs derived from B6 mice. 28 It is well known that these mycoplasmas are recognized by TLR2. M. salivarium, 29 was also used as a stimulator, because FSL-1 is directly recognized by TLR2. 12, 13, 15 In the following studies, only IL-1β was measured, because the amount of IL-1β secreted was higher than IL-1α
and IL-18 secretion (Figure 1 ). It was demonstrated that MsLP, MpLP, and FSL-1 induced IL-1β secretion by B6BMMs (Figure 2A , B and C). The results are expressed as the mean ± SD of triplicate assays of a representative experiment. All of the experiments were repeated at least twice, and similar results were obtained. Student's t-test; *.01 < P < .05, **.01 < P < .001, ***P < .001
| IL-1β production by
, or ASC −/− BMMs) ( Figure 3A , B and C). These results suggest that one of the mycoplasmal active entities that activate the NLRP3 inflammasome to induce IL-1β production are lipoproteins/lipopeptides.
| Effect of proteinase K on the IL-1β-inducing activity of mycoplasmal lipoproteins
We have previously shown that the production of IL-6 and tumor necrosis factor-α by normal human gingival fibroblasts and the human monocytic cell line THP-1 in response to MsLP depends on the N-terminal lipid moiety, but not the proteinaceous moiety. 29 In addition, the recognition site of mycoplasmal lipoproteins by TLR2/6 is the N-terminal lipopeptide. 13 Therefore, the IL-1β-inducing activities of MsLP and MpLP digested by proteinase K were examined. Both MsLP and MpLP were clearly digested by proteinase K ( Figure 4A ). However, the activities of MsLP and MpLP were not downregulated, but rather were upregulated by the proteinase K treatment ( Figure 4B ), suggesting that the active entities of these lipoproteins were proteinase K-resistant, possibly their N-terminal lipopeptide moieties.
| Transfection of mycoplasmal lipopeptide into the cytosol
It has been reported that cytosolic entry of bacteria or bacterial ligands is required for activation of inflammasomes upon infection with various bacteria. 6 Therefore, we investigated whether the mycoplasmal lipopeptide FSL-1 exists in the cytosol of B6BMMs by using FITC-labeled FSL-1, and found that FSL-1 does indeed exist within the cytosol ( Figure 5A ).
In addition, we investigated whether IL-1β production was enhanced by the artificial delivery of FSL-1 into the cytosol of B6BMMs with the protein transfection reagent PULSin. It was found that the transfection drastically enhanced the amount of FSL-1 in the cytosol ( Figure 5A ) and also enhanced the IL-1β-inducing activity ( Figure 5B ). These results suggest that the localization of FSL-1 in the cytosol is an important process leading to the activation of the NLRP3 inflammasome. 
| The subcellular distribution of internalized lipopeptide
We confirmed that FSL-1 localizes in the cytosol of B6BMMs at 4 hours after incubation with FSL-1 ( Figure 5A ). Previously, we have found that FSL-1 is internalized into a murine macrophage cell line, RAW 264.7 cells in a clathrin-dependent endocytic pathway. 32 Therefore, we wanted to know how FSL-1 translocates into the cytosol of B6BMMs. aggregates called 'speck' or 'pyroptosome'. [33] [34] [35] [36] [37] [38] Therefore, the next experiment was carried out to investigate whether FSL-1 induces and is co-localized with the NLRP3/ASC speck in B6BMMs.
It was found that FSL-1, as well as the representative NLRP3 inflammasome stimulator nigericin, induced the NLRP3/ASC speck, but FSL-1 was not co-localized with the speck (Figure 7A , B).
| D ISCUSS I ON
This study demonstrated that one of the active entities of M. salivarium and M. pneumoniae capable of stimulating the NLRP3 inflammasome to produce IL-1β in murine BMMs are their membrane-bound lipoproteins (Figure 2, 3) . Consistent with our results, the ability of mycoplasmal lipoproteins and lipopeptides to induce the secretion of proinflammatory cytokines including IL-1β, tumor necrosis factor-α, and IL-6 has been reported. 29, [39] [40] [41] [42] [43] [44] [45] We also showed that the active entities that stimulate the NLRP3 inflammasome were 
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